You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 40 No. 8, August 1983 TABLE OF CONTENTS
  Archives
  •  Online Features
  ARTICLES
 This Article
 •References
 •Full text PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Pathogenesis of Coronavirus SD in Mice

I. Prominent Demyelination in the Absence of Infectious Virus Production

Paul M. Mendelman, MD; Lynn D. Jankovsky, DVM, PhD; Ronald S. Murray, MD; Patricia Licari; Bonnie DeVald; John C. Gerdes, PhD; Jack S. Burks, MD

Arch Neurol. 1983;40(8):493-498.


Abstract

• Following intracerebral inoculation of 3- to 4-week-old C57 B 16/J mice with coronavirus SD, 23% exhibited neurologic signs within the first week. However, only 6% died. Within the first week after inoculation (AI), we noted a panencephalitis. Prominent demyelination detected in the spinal cord on day 6 continued through day 29 AI. Demyelinated lesions in the spinal cord were either subpial with few inflammatory cells except for macrophages or perivascular with prominent accumulation of lymphocytes, plasma cells, and macrophages. Beginning on day 6 AI, IgG was detected in the lesions. Although an infectious virus was detectable in the CNS only through day 12 AI, viral antigen expression continued through day 24. We concluded that coronavirus SD persists in a nonrecoverable form throughout the initial phase of demyelination, day 6 to day 24 AI.



Author Affiliations

From the Division of Infectious Disease, Department of Pediatrics, Childrens Orthopedic Hospital and Medical Center, School of Medicine, University of Washington, Seattle (Dr Mendelman); Departments of Pathology (Dr Jankovsky), Neurology (Drs Murray, Gerdes, and Burks), and Immunology (Drs Gerdes and Burks), Rocky Mountain Multiple Sclerosis Center, University of Colorado Health Sciences Center, School of Medicine; and Veterans Administration Medical Center (Mss Licari and DeVald and Drs Gerdes and Burks), Denver.


Footnotes

Accepted for publication Dec 29, 1982.

Reprint requests to University of Colorado Health Sciences Center, Box B181, 4200 E Ninth Ave, Denver, CO 80262 (Dr Burks).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Antigenic Assessment of Coronaviruses Isolated From Patients With Multiple Sclerosis
Fleming et al.
Arch Neurol 1988;45:629-633.
ABSTRACT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1983 American Medical Association. All Rights Reserved.